Vaccine consisting of recombinant Hin47 protein of H. influenzae: Phase I Update

Antex Biologics Inc. (ANTX), Gaithersburg,

Read the full 54 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE